Gesundheit
Deutsche Aufsichtsbehörde genehmigt Übernahme von Cardior Pharmaceuticals durch Novo
Germany’s cartel authority has approved a deal with Denmark’s Novo Nordisk to buy Cardior Pharmaceuticals, the regulator said in a statement on Thursday. The acquisition
Bericht: Nestlé fügt Säuglingsmilch in ärmeren Ländern Zucker hinzu
Public Eye, a Swiss organisation, reported Nestlé adds sugar and honey to infant milk sold in many poorer countries, after testing samples of the baby-food
Schwarze Frauen leiden in England häufiger unter schweren Geburtskomplikationen
A report published by English newspaper The Guardian reveals black women are up to six times more likely to experience a serious birth complication during
Sage Therapeutics stoppt Entwicklung eines Parkinson-Medikaments
Sage Therapeutics Parkinson’s treatment drug failed in a midstage study, with the company’s stock collapsing to a record low. Sage has decided to stop developing
Patienten mit Schlafapnoe reagieren in Studien auf Eli Lillys Medikament zur Gewichtsabnahme
Zepbound has been found to reduce sleep apnea, according to two studies conducted by its producer Eli Lilly. Findings were announced in a news release,
GSK bekräftigt Wirksamkeit des Gürtelrose-Impfstoffs
British drugmaker GSK said its blockbuster shingles vaccine Shingrix showed 79.7% efficacy in long-term data. The study took participants aged 50 years and above, in
Britische Parlamentarier stimmen für Rauchverbot für die jüngere Generation
British lawmakers will vote Tuesday on Prime Minister Rishi Sunak’s decision to ban those aged 15 and under from ever buying cigarettes. The law is
Tansania, Ruanda und Simbabwe schließen sich dem Hustensaft-Rückruf von J&J in Afrika an
Drug regulators in Tanzania, Rwanda and Zimbabwe have recalled a batch of Johnson & Johnson paediatric cough syrup as a precautionary measure after its Nigerian
Über 250 Websites verkaufen gefälschte Medikamente zur Gewichtsabnahme
Cybersecurity firm BrandShield took down over 250 websites that sold fake versions of weight-loss and diabetes drugs in the GLP-1 class. In an interview with
UnitedHealth-Hack wirft Schatten auf Ergebnisbericht des ersten Quartals
UnitedHealth is expected to post higher medical costs in its first earnings report since a cyberattack disrupted its technology systems, including those that handle prescriptions